Neurizon unveils preclinical protein clearance data
Neurizon Therapeutics (ASX:NUZ) has unveiled compelling new preclinical data regarding its lead compound, NUZ-001.
Neurizon Therapeutics (ASX:NUZ) has unveiled compelling new preclinical data regarding its lead compound, NUZ-001.
Lindian Resources (ASX:LIN) announced a $100 million institutional placement to fast-track its flagship Kangankunde Rare Earths Project.
Metgasco (ASX:MEL) terminates the sale of its 25% interest in the Odin and Vali gas fields to Vintage Energy (ASX:VEN) after pre-conditions were not met.
Australia and Anthropic sign a landmark MoU to accelerate responsible AI adoption, securing a $3 million research boost.
Penguin Solutions (NASDAQ:PENG) reported its financial results for the second quarter of fiscal 2026 on Wednesday, April 1.
VSee Health (NASDAQ:VSEE) reported its financial and operational results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.
WTW (NASDAQ:WTW), a leading global advisory, broking, and solutions company, announced on Wednesday, April 1, 2026, that it has successfully completed the acquisition of FlowStone Partners.
Largo (NASDAQ:LGO) reported its financial and operational results for the fourth quarter and full year ended December 31, 2025, on Wednesday, April 1, 2026.
Eli Lilly and Company (NYSE:LLY) announced on Wednesday, April 1, 2026, that the U.S. Food and Drug Administration (FDA) has approved Foundayo™ (orforglipron) for chronic weight management in adults with obesity, or those who are overweight with at least one weight-related condition.
UniFirst (NYSE:UNF) reported financial results for its second quarter of fiscal 2026, ended February 28, 2026, on Wednesday, April 1.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy
